These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8786987)

  • 1. Oxidation of recombinant human parathyroid hormone: effect of oxidized position on the biological activity.
    Nabuchi Y; Fujiwara E; Ueno K; Kuboniwa H; Asoh Y; Ushio H
    Pharm Res; 1995 Dec; 12(12):2049-52. PubMed ID: 8786987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological Activity of Different Forms of Oxidized Parathyroid Hormone.
    Hasan AA; Hocher CF; Kleuser B; Krämer BK; Hocher B
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide mapping of recombinant human parathyroid hormone by enzymatic digestion and subsequent fast-atom bombardment mass spectrometry.
    Nabuchi Y; Kuboniwa H; Takasu H; Asoh Y; Ushio H
    Rapid Commun Mass Spectrom; 1995; 9(4):257-60. PubMed ID: 7756699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin - evidence from in vitro and human studies.
    Li M; Hasan AA; Chu C; Hocher JG; Liu Y; Zhang X; Chen X; Yard B; Krämer BK; Hocher B
    Pflugers Arch; 2024 Jun; 476(6):889-899. PubMed ID: 38393416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stability and degradation pathway of recombinant human parathyroid hormone: deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues.
    Nabuchi Y; Fujiwara E; Kuboniwa H; Asoh Y; Ushio H
    Pharm Res; 1997 Dec; 14(12):1685-90. PubMed ID: 9453054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modes of Degradation and Impurity Characterization in rhPTH (1-34) during Stability Studies.
    Kothari R; Kumar V; Jena R; Tunga R; Tunga BS
    PDA J Pharm Sci Technol; 2011; 65(4):348-62. PubMed ID: 22293522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structural and mechanistic study of the oxidation of methionine residues in hPTH(1-34) via experiments and simulations.
    Chu JW; Yin J; Wang DI; Trout BL
    Biochemistry; 2004 Nov; 43(44):14139-48. PubMed ID: 15518564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized forms of parathyroid hormone with biological activity. Separation and characterization of hormone forms oxidized at methionine 8 and methionine 18.
    Frelinger AL; Zull JE
    J Biol Chem; 1984 May; 259(9):5507-13. PubMed ID: 6715358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization.
    Ji JA; Zhang B; Cheng W; Wang YJ
    J Pharm Sci; 2009 Dec; 98(12):4485-500. PubMed ID: 19455640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined application of high resolution and tandem mass spectrometers to characterize methionine oxidation in a parathyroid hormone formulation.
    Pan C; Valente JJ; LoBrutto R; Pickett JS; Motto M
    J Pharm Sci; 2010 Mar; 99(3):1169-79. PubMed ID: 19711445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective oxidation of 1-34 bovine parathyroid hormone on its renal actions in the rabbit.
    Pitts TO; Puschett JB; Rose ME; Zull JE
    Miner Electrolyte Metab; 1989; 15(5):267-75. PubMed ID: 2554103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of Methionine to Asparagine but Not Leucine in Parathyroid Hormone Mimics the Loss of Biological Function upon Oxidation.
    Gaur A; Lipponen J; Yang Y; Armen RS; Wang B
    Biochemistry; 2022 Jun; 61(11):981-991. PubMed ID: 35533300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large scale preparation of recombinant human parathyroid hormone 1-84 from Escherichia coli.
    Liu Q; Lin J; Liu M; Tao X; Wei D; Ma X; Yang S
    Protein Expr Purif; 2007 Aug; 54(2):212-9. PubMed ID: 17449274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of methionine oxidation on the aggregation of recombinant human growth hormone.
    Mulinacci F; Poirier E; Capelle MA; Gurny R; Arvinte T
    Eur J Pharm Biopharm; 2013 Sep; 85(1):42-52. PubMed ID: 23958317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function studies of analogues of parathyroid hormone (PTH)-1-34 containing beta-amino acid residues in positions 11-13.
    Peggion E; Mammi S; Schievano E; Silvestri L; Schiebler L; Bisello A; Rosenblatt M; Chorev M
    Biochemistry; 2002 Jun; 41(25):8162-75. PubMed ID: 12069609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of two biologically active O-glycosylated forms of human parathyroid hormone produced in Saccharomyces cerevisiae. Identification of a new motif for O-glycosylation.
    Olstad OK; Reppe S; Gabrielsen OS; Hartmanis M; Blingsmo OR; Gautvik VT; Haflan AK; Christensen TB; Oyen TB; Gautvik KM
    Eur J Biochem; 1992 Apr; 205(1):311-9. PubMed ID: 1555591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between light induced and chemically induced oxidation of rhVEGF.
    Duenas ET; Keck R; De Vos A; Jones AJ; Cleland JL
    Pharm Res; 2001 Oct; 18(10):1455-60. PubMed ID: 11697472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective proteolysis of the receptor for parathyroid hormone in renal cortex.
    Chase LR
    Endocrinology; 1975 Jan; 96(1):70-6. PubMed ID: 162881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro refolding with simultaneous purification of recombinant human parathyroid hormone (rhPTH 1-34) from Escherichia coli directed by protein folding size exclusion chromatography (PF-SEC): implication of solution additives and their role on aggregates and renaturation.
    Vemula S; Vemula S; Dedaniya A; Ronda SR
    Anal Bioanal Chem; 2016 Jan; 408(1):217-29. PubMed ID: 26472319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid determination of oxidized methionine residues in recombinant human basic fibroblast growth factor by ultra-performance liquid chromatography and electrospray ionization quadrupole time-of-flight mass spectrometry with in-source collision-induced dissociation.
    Ohkubo T; Inagaki S; Min JZ; Kamiya D; Toyo'oka T
    Rapid Commun Mass Spectrom; 2009 Jul; 23(13):2053-60. PubMed ID: 19504477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.